Noxipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic Pain - Full Text View

Purpose

The purpose of this study is to validate the efficacy of Noxipoint(TM) therapy on chronic pain, and compare it with standard physical therapy using electrical stimulation on patients with chronic pain.

Invented by Dr. Charlie Koo at Stanford University, Noxipoint Therapy is a specific procedure with precise location, duration and intensity of TENS stimulation within the general FDA guidelines. The therapy substantially relieves general muscular/tendon pain and persistently restores the muscle and tendon function. The surface locations of nociceptors at the free nerve ending (i.e., "Noxipoints") are focused on in the stimulation therapy. Multiple clinical uses of Noxipoint Therapy confirmed the consistent efficacy of such stimulation at Noxipoints. An observational study of Noxipoint therapy within the FDA-approved use of TENS demonstrated an encouraging 93% success rate in eliminating the chronic pain, such as frozen shoulder pain, within 2-3 sessions. It is an order-of-magnitude improvement over the non-specific application of TENS and any other modalities in pain treatment. A unique neuro-immuno-signaling pathway that implicates the activation of adult stem cells, such as satellite cells in muscles, is implicated based on such a high success rate.

Condition	Intervention
Shoulder Pain Neck Pain	Procedure: Noxipoint Therapy Procedure: Physical Therapy


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Participant, Outcomes Assessor) Primary Purpose: Treatment
Official Title:	Noxipoint Therapy vs. Standard Physical Therapy Using Electrical Stimulation for Chronic Pain

Resource links provided by NLM:

MedlinePlus related topics: Chronic Pain Health Checkup

U.S. FDA Resources

Further study details as provided by Pain Cure Center, California:

Primary Outcome Measures:

Brief Pain Inventory (BPI) Severity of the Pain at Its Worst [ Time Frame: One year ]
BPI will be evaluated as the score change from the baseline. As a supplemental measure, the baseline of individual patients will also be normalized to 100%, with the change being a percentile of the baseline.

Secondary Outcome Measures:

BPI Severity of the pain in the other three occasions [ Time Frame: One year ]
Besides the Severity of the Pain at Its Worst, there are three other pain measures in BPI. This measure will be used as a supporting measure fo the Primary Measure.
BPI Interference of Function [ Time Frame: One year ]
This measure is used to indicate the impact of the subject's quality of life. However, the standard questions include the therapy's functional impact on walking, which is not likely to be influenced by neck/shoulder pains in any case and thus may not be relevant. Thus, a supplemental measure excluding the impact on walking will be provided as a supplemental observation.
Range of motion [ Time Frame: One year ]
This measure will be taken whenever possible.
Shoulder Pain and Disability Index (SPADI) [ Time Frame: One year ]
SPADI will be taken from shoulder pain patients whenever possible. This is optional.
Neck Disability Index (NDI) [ Time Frame: One year ]
NDI will be taken from neck pain patients whenever possible. This is optional.


Enrollment:	34
Study Start Date:	April 2012
Study Completion Date:	February 2013
Primary Completion Date:	February 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Noxipoint Therapy	Procedure: Noxipoint Therapy Patients will be treated with a TENS device, following Noxipoint Therapy guidelines: Find the cause of the pain via Noxipoint: For each injured muscle/tissue, it is discovered that there are always a pair of points at the skin surface locations of its nociceptors that are painful at light press (named "Noxipoints"). Stimulate the corresponding pair of Nocipoints following a narrowly defined combination of intensity/ frequency (inducing the C-fiber response) and duration (about 1.5-3 minutes) of TENS at the two targeted Noxipoints. Repeat (a) to (b) above for each identified injured muscle group until all pain areas are eliminated or when the session time is up. Instruct the subject not to use the newly recovered muscle/tissue too much an estimated rest period depending on his/her age. Other Name: Koo's Pain Cure Therapy
Active Comparator: Physical Therapy	Procedure: Physical Therapy The 1.5-hour physical therapy in the control arm are provided both as standard of care and sham device comparison to Nocipoint Therapy, following these guidelines: TENS stimulation (45 minutes): • Electrodes will be placed around the patient-identified general pain area on the neck /shoulder for TENS. Rotate the electrode pads around the pain area and stimulate again. Other modalities of PT per the therapist's choice: Infrared treatment on the pain areas (about 15 minutes) Manual therapy to cervical and/or rotator cuff areas (about 15 minutes). Exercise and training: Neck exercises: Range of motion exercises to include foraminal opening for about 15 minutes, and/or Shoulder exercise: Range of motion exercises to include walking the arm on the wall, rotation of the upper arm for about 15 minutes Hot/cold pack to the pain area for about 15 minutes Other Name: PT

Arms

Assigned Interventions

Experimental: Noxipoint Therapy

Procedure: Noxipoint Therapy

Patients will be treated with a TENS device, following Noxipoint Therapy guidelines:

Find the cause of the pain via Noxipoint: For each injured muscle/tissue, it is discovered that there are always a pair of points at the skin surface locations of its nociceptors that are painful at light press (named "Noxipoints").
Stimulate the corresponding pair of Nocipoints following a narrowly defined combination of intensity/ frequency (inducing the C-fiber response) and duration (about 1.5-3 minutes) of TENS at the two targeted Noxipoints.
Repeat (a) to (b) above for each identified injured muscle group until all pain areas are eliminated or when the session time is up.
Instruct the subject not to use the newly recovered muscle/tissue too much an estimated rest period depending on his/her age.

Other Name: Koo's Pain Cure Therapy

Active Comparator: Physical Therapy

Procedure: Physical Therapy

The 1.5-hour physical therapy in the control arm are provided both as standard of care and sham device comparison to Nocipoint Therapy, following these guidelines:

TENS stimulation (45 minutes):

• Electrodes will be placed around the patient-identified general pain area on the neck /shoulder for TENS. Rotate the electrode pads around the pain area and stimulate again.
Other modalities of PT per the therapist's choice:
- Infrared treatment on the pain areas (about 15 minutes)
- Manual therapy to cervical and/or rotator cuff areas (about 15 minutes).
- Exercise and training:
  - Neck exercises: Range of motion exercises to include foraminal opening for about 15 minutes, and/or
  - Shoulder exercise: Range of motion exercises to include walking the arm on the wall, rotation of the upper arm for about 15 minutes
- Hot/cold pack to the pain area for about 15 minutes

Other Name: PT

Detailed Description:

View http://paincurecenter.com/Clinical_Outcome.html for the observational study mentioned in the Brief Summary above. For more detailed cases, please view http://paincurecenter.com/uploads/Nocipoint_therapy_clinical_study_w_o_ID_2011-2012.pdf

Eligibility


Ages Eligible for Study:	18 Years to 64 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

18-64 years old male or female
Having chronic pain (ICD-9: 338.21, 338.29) in the neck/upper back (ICD-9: 723.1), or the shoulder (ICD-9: 719.41)
Pain duration over 6 months, with at least one month of history of other therapy treatments (Physical therapy, steroid injection, acupuncture, analgesic medicine, and/or massage therapy)

Exclusion Criteria:

Patients with BPI Severity at its Worst below 5
Traumatic injury from external impact force
Pain caused by traumatic bone fractures
History of traumatic cervical injury
History of osteoporosis
Pain related to systemic inflammatory conditions including polymyalgia rheumatic, systemic lupus erythematosis
Signs of psychosomatic illness
Severe rheumatoid arthritis undergoing active treatment including DMARD biologics
Steroid injection on pain site within 4 weeks
Language and/or cognitive inability to complete the assessment questionnaires
Previous TENS for pain relief
For safety reasons, patients wearing cardiac pace makers, implanted defibrillator, or pregnant women

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01578148

Locations


United States, California
Pain Cure Center
Palo Alto, California, United States, 94306

Sponsors and Collaborators

Pain Cure Center, California

Investigators


Study Director:	Charles C Koo, PhD	Pain Cure Center
Principal Investigator:	Charles C Koo, PhD	Pain Cure Center
Principal Investigator:	David Lewis, MD	Stanford University

More Information


Responsible Party:	Pain Cure Center, California
ClinicalTrials.gov Identifier:	NCT01578148 History of Changes
Other Study ID Numbers:	NT-01-2012
Study First Received:	April 13, 2012
Last Updated:	April 23, 2013

Keywords provided by Pain Cure Center, California:


Cervical pain Cervicalgia, Cervicodynia Neck ache	Neckache Shoulder pain Shoulder impingement syndrome

Additional relevant MeSH terms:


Chronic Pain Neck Pain Shoulder Pain Pain Neurologic Manifestations	Nervous System Diseases Signs and Symptoms Arthralgia Joint Diseases Musculoskeletal Diseases

ClinicalTrials.gov processed this record on July 21, 2017